CME GroupCME +4.61%91 EPS without NRI is $11.77 as of Mar. 2026. GuruFocus rates CME with a GF Score™ of 91/100 and a GF Value™ of $271.18 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 583 Capital Markets companies, CME Group ranks worse than 52.14% on this metric.
CME Group's earnings per share without non-recurring items for the
three
months ended in Mar. 2026 was $3.36.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $11.77.
During the past 12 months, CME Group's average earnings per share (NRI) Growth Rate was 11.50% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 12.00% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was 12.10% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 10.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for CME Group's EPS without NRI or its related term are showing as below:
CME'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -14.9 Med: 13.5 Max: 45.7
Current: 12
During the past 13 years, CME Group's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 45.70% per year. The lowest was -14.90% per year. And the median was 13.50% per year.
CME's 3-Year EPS without NRI Growth Rate is ranked worse than 52.14% of 583
companies
in the Capital Markets industry
Industry Median: 13.6
vs CME: 12.00
CME Group's EPS (Diluted) for the
three
months ended in Mar. 2026 was $3.18.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $11.72.
CME Group's EPS (Basic) for the
three
months ended in Mar. 2026 was $3.25.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $11.80.
CME Group (NAS:CME) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
CME Group EPS without NRI Related Terms
CME Group EPS without NRI Historical Data
* Premium members only.
The historical data trend for CME Group's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Financial Data & Stock Exchanges subindustry, CME Group's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CME Group PE Ratio without NRI vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, CME Group's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where CME Group's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.77
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CME Group (CME) has a EPS without NRI of $11.77 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on CME Group and its competitors. According to the industry distribution chart, CME Group ranks #304 out of 583 companies in the Capital Markets industry, placing it in the top 52.1%.
Is CME Group's EPS without NRI too high?
CME Group's current EPS without NRI is $11.77. The Capital Markets industry median EPS without NRI is 13.60. CME Group's value of $11.77 is 13.5% below this industry median. Based on the distribution chart, CME Group ranks #304 out of 583 companies in the Capital Markets industry, which is below the industry midpoint. Overall, CME Group has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CME Group's EPS without NRI compare to MCO and ICE?
According to the Capital Markets industry distribution chart, CME Group ranks #304 out of 583 companies for EPS without NRI. This places CME Group in the lower half of its industry. The industry median EPS without NRI is 13.60. CME Group's value of $11.77 is 13.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Capital Markets company?
The median EPS without NRI among Capital Markets companies is 13.60, based on 583 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CME Group's current EPS without NRI of $11.77 is 13.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on CME Group and its competitors. For the Capital Markets industry, the median EPS without NRI is 13.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CME Group's current EPS without NRI is $11.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CME Group stock overvalued right now?
Based on GuruFocus' analysis, CME Group (CME) is currently considered Modestly Undervalued. The stock's GF Value™ is $271.18, compared to a current price of $231.00 — trading 14.8% below its estimated fair value. The current EPS without NRI is $11.77 and 13.5% below the Capital Markets industry median of 13.60. CME Group's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For CME Group (CME), the current EPS without NRI is $11.77 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CME Group (CME) Overvalued in 2026?
Based on GuruFocus' analysis, CME Group stock appears to be undervalued.
The current stock price of $231.00 is trading 14.8% below its estimated GF Value™ of $271.18.
GuruFocus considers CME Group to be Modestly Undervalued.
Key valuation signals for CME:
EPS without NRI: $11.77
GF Value™: $271.18 vs. price of $231.00 (14.8% below fair value)
Industry Position: 13.5% below the Capital Markets median (#304 of 583)
No single metric tells the full story. See the CME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
91GF Score
Get the complete analysis for CME
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CME has been successfully added to your 
